Please login to the form below

Not currently logged in
Email:
Password:

Shire and TAP in joint sales drive

Specialty biopharmaceuticals company Shire announced on March 26 a joint sales agreement to promote its drug Lialda (mesalamine) in the US
Specialty biopharmaceuticals company Shire announced on March 26 a joint sales agreement to promote its drug Lialda (mesalamine) in the US.

The three-year agreement has been made with TAP Pharmaceutical Products based in Philadelphia in the US to increase sales of Lialda.

Lialda has been developed for use as a once daily oral formulation indicated for the induction of remission in patients with active mild to moderate ulcerative colitis.

Mike Yasick, senior vice president of Shire's gastrointestinal business unit, said: "Aligning with TAP, one of the most successful and well-respected GI sales organisations in the industry, is a tremendous benefit for Shire as it will quadruple the Lialda sales force across the United States."

"Shire's GI team has made Lialda the fastest growing brand of mesalamine and with his collaboration we will bolster the frequency of sales calls to our existing base of specialist physicians," he added.

Tim Rudolphi, vice president of TAP's gastroenterology marketing franchise, said: "This connection with Shire is a natural fit for our sales force, and is a win for all involved, especially the patient population who may benefit most."

27th March 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....
Personas: a top tool for personalising pharma marketing campaigns
Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively....

Infographics